About Robert Palmisano
Robert Palmisano is CEO and director at AEON Biopharma.
Form D filings name Robert Palmisano as a director at Saluda Medical.
Robert Palmisano reports to the SEC as a director, officer or major shareholder of 9 public companies, including RxSight (RXST), Wright Medical Group N.V. (WMGI) and Avedro (AVDR).
Robert Palmisano first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Palmisano in the role, so the role may have started earlier or lasted longer.
AI
AEON Biopharma, Inc.
CEO and director
2021 – 2026 · Public company (AEON)
RI
RxSight, Inc.
Director
2021 – 2026 · Public company (RXST)
WV
Wright Medical Group N.V.
President and CEO, director
2015 – 2020 · Public company (WMGI)
AI
Avedro Inc.
Director
2019 · Public company (AVDR)
WI
Wright Medical Group Inc.
President and CEO, director
2011 – 2015 · Public company (WMGI)
OI
Osteotech Inc.
Director
2006 – 2010 · Public company (OSTE)
EI
ev3 Inc.
President and CEO, director
2008 – 2010 · Public company (EVVV)
AI
Abbott Medical Optics Inc.
Director
2007 – 2009 · Public company (EYE)
IC
Intralase Corp.
President & CEO, director
2006 – 2007 · Public company (ILSE)
Key Colleagues at Startups
The people Robert Palmisano works with at each company, as listed on that company's latest Form D.
Saluda Medical, Inc. · Form D, Nov 12, 2025
GP
Greg Plamondon
Executive officer
KC
Kristin Caplice
Chief Legal Officer and Secretary
JM
Juan-Pablo Mas
Director
RF
Robert Faulkner
Director
DG
Doug Godshall
Director
GB
Geoffrey Brooke
Director
BR
Barry Regan
Executive officer and director
CL
Catherine Livingstone
Director
CB
Chris Beare
Director
AC
Andrew Cleeland
Director